Kimberly serves as the project lead for GSK’s Inflation Reduction Act Planning and Implementation team, making her the single point of accountability.
She coordinates GSK’s efforts to adapt to the law’s provisions and ensures the IRA’s impact is included in strategic and operating assessments. Kimberly also engages with government agencies and other groups to discuss how the IRA may impact patient access to essential therapies and innovation.